Douglas Simpson

Doug Simpson is a senior healthcare finance executive. As of late 2024 he serves as President of Panoramic Health, an integrated nephrology provider group (headquartered in Tempe, AZ) focused on value-based kidney care. He joined Panoramic Health in 2023 as Executive Vice President & Chief Financial Officer (October 2023) and was elevated to President in November 2024.

Before Panoramic Health, Simpson was Executive Vice President & Chief Financial Officer of Horizon Blue Cross Blue Shield of New Jersey from November 2018 to 2022. In that role he oversaw the company's financial strategy and actuarial functions — accounting and financial reporting, treasury and capital planning, investments, tax, budgeting and planning, procurement and corporate real estate, the special investigations unit, security, and administration.

Earlier in his career, Simpson spent several years at Anthem, Inc. in a series of senior finance roles, including SVP & CFO of the Government Business Division, CFO of National Accounts, SVP & CFO of Business Operations, and leadership of Enterprise Financial Reporting & Analysis and Investor Relations. Prior to Anthem, he spent over 15 years in equity research as a sell-side analyst covering the managed care and healthcare provider industries at Wall Street firms including Morgan Stanley (as an Executive Director / Senior Analyst), Merrill Lynch, and Bear Stearns.

Simpson earned a B.S. in Business Administration from Bucknell University (1994) and an MBA from The Wharton School at the University of Pennsylvania (2002).

• No public angel or venture investing thesis was found. Douglas Simpson's documented profile is that of a corporate finance executive (CFO/President), not a named angel or seed-stage investor. The "Angel Investors / Seed Round" framing in the source stub could not be corroborated by any primary or secondary source.
• His professional expertise, where relevant to any investor evaluation, sits squarely in U.S. healthcare: managed care and health insurance economics, value-based care, and nephrology/kidney-care delivery.
• As a former long-tenured sell-side equity research analyst covering managed care and providers, he brings a rigorous, financials-first lens to healthcare business models.